What is the future of precision medicine in the EU? The field of precision medicine is a complex are...
Read moreThe law provides a legal framework for the automatic substitution of biosimilars at the level of the...
Read moreCanadians pay too much for prescription drugs – and that means far too many go without the medicin...
Read moreInitially NICE rejected Illumetri for not being cost-effective, but a new negotiated price means th...
Read moreSpeaking at the international pharma conference, NICE’s chief executive Sir Andrew Dillon struck a...
Read moreAdults with lymphoma will not be able to access Novartis’ CAR-T therapy Kymriah on the NHS in Scot...
Read moreA new game changing treatment for people with multiple myeloma will now be available on the NHS in E...
Read moreConclusion: Blincyto has significant clinical benefits, but that further evidence on cost-effective...
Read moreUnderstanding payer value and evidence requirements to secure pricing and reimbursement for a novel ...
Read moreAt the current rate, annual deaths due to AMR is expected to reach 10 million by 2050 globally, with...
Read more